跳至主要内容
临床试验/DRKS00014645
DRKS00014645已完成未知

Poly-stakeholders integrated care for chronic patients in acute phases - POLYCARE

niversitätsklinikum Bonn - Studienzentrale SZB - Institut für klinische Chemie und klinische Pharmakologie0 个研究点目标入组 7 人开始时间: 2018年5月7日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
7

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
65 Years 至 one(—)
性别
All

入选标准

  • Age = 65 years
  • Living in the area of coverage
  • Patients with the ability to follow study instructions and likely to attend and complete all required visits
  • Written informed consent
  • Supported by either a nursing service or an informal carer living in the same household
  • Appropiate Housing Conditions
  • Informal carer available (at least by telephone) all day
  • Having social needs, defined as
  • Barber at least 2 answers in the affirmative + Any Barthel-Score OR
  • Barthel-Score between 80 and 95 + Barber at least 1 answer in the affirmative OR
  • Barthel-Score 75 or less + any Barber
  • COPD exacerbation (without indication for in-patient treatment according to the GP)
  • physician-diagnosed COPD (defined as FEV1/ FVC <70%)
  • new exertional dyspnea or worsening of existing exertional dyspnea
  • necessity of a systemic therapy with antibiotics and/or corticosteroids
  • Decompensated heart failure (without indication for in-patient treatment according to the GP)
  • physician-diagnosed heart failure (all functional classes)
  • At least one of the following symptoms
  • o new exertional dyspnea or worsening of existing exertional dyspnea
  • o new peripheral oedema or worsening of existing oedema
  • o increase in weight of = 2 kg within 5 days or less
  • necessity of new medication with a (additional) diuretic or modification (increase) of an existing diuretic therapy
  • Pneumonia (without indication for in-patient treatment according to the GP)
  • Suspected pneumonia by the GP PLUS at least one of the following
  • o Corresponding auscultation of the lung
  • o Elevated CRP
  • o Corresponding Chest-x-ray
  • At least two points in the Charlson Comorbidity Index (CCI)
  • Pyelonephritis (without indication for in-patient treatment according to the GP)
  • Suspected pyelonephritis by the GP PLUS at least one of the following:
  • o Elevated CRP
  • o Corresponding urine test strip
  • o Corresponding ultrasound
  • At least two points in the Charlson Comorbidity Index (CCI)
  • Erysipel (without indication for in-patient treatment according to the GP)
  • Suspected erysipel by the GP
  • At least two points in the Charlson Comorbidity Index (CCI)

排除标准

  • Patients not able to give consent
  • Necessity of hospitalization according to the appraisal of the GP
  • Severe dyspnea
  • Oxygen saturation < 90% (if measured)
  • Rapid progression of symptoms
  • Clouding of conscioussness
  • Central cyanosis
  • Uncertain diagnosis
  • Hypotension, defined as systolic blood pressure < 100 mmHg
  • Pulmonary oedema
  • New or hemodynamic relevant arrhythmias (including new atrial fibrillation)
  • Patients without legal capacity who is unable to understand the nature, scope, significance and consequences of this clinical trial
  • Patients with implanted pacemaker or ICD-system
  • Patients with severe mental retardation, psychiatrical disorders or other cognitive impairment resulting in incapability to adequately estimate the risks and benefits of study participitation (e.g. advanced dementia)
  • Patient lacks suitability for Polycare in estimation of the local Polycare-Team (consisting of staff of SZB and IfH of the UKB)

研究者

发起方
niversitätsklinikum Bonn - Studienzentrale SZB - Institut für klinische Chemie und klinische Pharmakologie

相似试验

Poly-stakeholders integrated care for chronic... | 临床试验